Appendix 4D and Half Year Report
Filed with ASX · · 24 pages · English
Summary by 6ix AI
The report indicates a decline in revenue and a significant loss attributable to the owners of HeraMED Ltd compared to the previous period. Additionally, the company did not declare any dividends for this half-year.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from HeraMED
- Reinstatement to Quotation
- HeraMED completes $1.98 million placement
- Suspension from Quotation
- Grant Awarded to Advance AI Maternity Care with RMIT & DHCRC
- Customer Update & US Market Strategy
Later from HeraMED
- HeraMED accelerates its next generation AI roadmap
- HeraBEAT receives upgraded TGA regulatory classification
- Pause in Trading
- HeraMED partners with Philips for US maternity solution
- HeraMED partners with Lee Health- digital maternity solution
Follow HeraMED into a list and get an email when it puts out news.
Follow HeraMED